About the Authors

Ajit Lalvani

a.lalvani@imperial.ac.uk

Affiliations National Institute for Health Research Health Protection Research Unit in Respiratory Infections, Imperial College London, London, United Kingdom, Tuberculosis Research Centre, National Heart and Lung Institute, St Mary's Campus, Imperial College London, London, United Kingdom

Luis C. Berrocal-Almanza

Affiliation National Institute for Health Research Health Protection Research Unit in Respiratory Infections, Imperial College London, London, United Kingdom

Alice Halliday

Affiliations Tuberculosis Research Centre, National Heart and Lung Institute, St Mary's Campus, Imperial College London, London, United Kingdom, Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: AL is named inventor on patents pertaining to T-cell-based diagnosis, including current and second-generation IGRA technologies and flow-cytometric diagnosis and prognosis of tuberculosis infection and disease. Some of these patents were assigned by the University of Oxford, Oxford, UK, to Oxford Immunotec plc, resulting in the T-SPOT.TB test with royalty entitlements for the University of Oxford and AL. AH is named inventor on a patent pertaining to flow-cytometric diagnosis and prognosis of tuberculosis infection and disease. LBC has declared no competing interests exist.